Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer.
- Resource Type
- Article
- Source
Oncology Reviews . 2023, p1-4. 4p.- Subject
- *
OVARIAN cancer
*BIOMARKERS
*SINGLE-strand DNA breaks
*DOUBLE-strand DNA breaks
*OVARIAN epithelial cancer
*CLINICAL trials - Language
- ISSN
- 1970-5557